Bupivacaine Effectiveness and Safety in SABER® Trial
Public ClinicalTrials.gov record NCT01052012. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bupivacaine Effectiveness and Safety in SABER Trial (BESST)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a research study testing SABER-Bupivacaine (an experimental pain-relieving medication). SABER-Bupivacaine is designed to continuously deliver bupivacaine, a common local anesthetic, for a few days in order to treat local post-surgical pain. The purpose of this study is to investigate safety (side effects) associated with the use of SABER-Bupivacaine and how well it works in reducing pain and opioid-related side effects following various kinds of abdominal surgeries.
Study identification
- NCT ID
- NCT01052012
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 331 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Aug 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- May 31, 2021
2009 – 2011
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DURECT Study Site | Birmingham | Alabama | 35209 | — |
| DURECT Study Site | Florence | Alabama | 35630 | — |
| DURECT Study Site | Mobile | Alabama | 36608 | — |
| DURECT Study Site | Mobile | Alabama | 36617 | — |
| DURECT Study Site | Montgomery | Alabama | 36106 | — |
| DURECT Study Site | Sheffield | Alabama | 35660 | — |
| DURECT Study Site | Arcadia | California | 91007 | — |
| DURECT Study Site | Fontana | California | 92335 | — |
| DURECT Study Site | Laguna Hills | California | 92653 | — |
| DURECT Study Site | Pasadena | California | 91105 | — |
| DURECT Study Site | Tampa | Florida | 33606 | — |
| DURECT Study Site | Powder Springs | Georgia | 30127 | — |
| DURECT Study Site | Indianapolis | Indiana | 46206 | — |
| DURECT Study Site | Boston | Massachusetts | 02135 | — |
| DURECT Study Site | Troy | Michigan | 48085 | — |
| DURECT Study Site | Duluth | Minnesota | 55805 | — |
| DURECT Study Site | New York | New York | 10016 | — |
| DURECT Study Site | Durham | North Carolina | 27710 | — |
| DURECT Study Site | Columbus | Ohio | 43210 | — |
| DURECT Study Site | Hershey | Pennsylvania | 17033 | — |
| DURECT Study Site | Houston | Texas | 77024 | — |
| DURECT Study Site | Temple | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01052012, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01052012 live on ClinicalTrials.gov.